Francis Laurencio - 02 Mar 2026 Form 4 Insider Report for Atomera Inc (ATOM)

Role
CFO
Signature
/s/ Francis Laurencio, by Mindi Zimmer, as Attorney-in-Fact
Issuer symbol
ATOM
Transactions as of
02 Mar 2026
Net transactions value
-$23,755
Form type
4
Filing time
03 Mar 2026, 20:50:57 UTC
Previous filing
23 Feb 2026
Next filing
13 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Laurencio Francis CFO C/O ATOMERA, INC., 750 UNIVERSITY AVENUE, SUITE 280, LOS GATOS /s/ Francis Laurencio, by Mindi Zimmer, as Attorney-in-Fact 03 Mar 2026 0001680612

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATOM Common Stock Sale $2,168 -438 -0.29% $4.95 149,820 02 Mar 2026 Direct F1
transaction ATOM Common Stock Sale $5,519 -1,115 -0.74% $4.95 148,705 02 Mar 2026 Direct F1
transaction ATOM Common Stock Sale $4,787 -967 -0.65% $4.95 147,738 02 Mar 2026 Direct F1
transaction ATOM Common Stock Sale $11,281 -2,279 -1.5% $4.95 145,459 02 Mar 2026 Direct F1
transaction ATOM Common Stock Award $0 +28,626 +20% $0.000000 174,085 02 Mar 2026 Direct F2
transaction ATOM Common Stock Award $0 +57,252 +33% $0.000000 231,337 02 Mar 2026 Direct F3
transaction ATOM Common Stock Award $0 +28,626 +12% $0.000000 259,963 02 Mar 2026 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction pursuant to Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act.
F2 Each performance stock unit represents a contingent right to receive one share of common stock subject to achieving certain performance criteria. The performance period is January 1, 2026 through December 31, 2027 with vesting on March 1, 2028.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock of which 8.33% shall vest each quarter for the next 36 months commencing on June 1, 2026.
F4 Each performance stock unit represents a contingent right to receive one share of common stock subject to achieving certain performance criteria. The performance period is January 1, 2026 through December 31, 2028 with vesting on March 1, 2029.